Build it, and they will come. RSSL is upping services for small- and midsized biotechs with the launch of a new dedicated ...
Rapt Therapeutics is reeling from an “unfortunate and unexpected” clinical hold after a patient in a phase 2 immunology trial ...
Less than a month after Neuralink founder Elon Musk announced that the company’s brain-computer interface technology had been ...
Innovent Biologics is hoping that a phase 3 win for its thyroid eye disease (TED) treatment will provide a first shot at the ...
The collaboration between Everest Medicines and Providence Therapeutics back in 2021 marked a significant step up for the ...
Sanofi’s HIMALAYA adventure has ended (PDF) in failure, dealing another blow to its RIPK1 collaboration with Denali ...
More than a year after laying out a plan to divest its patient monitoring and respiratory interventions businesses—sparking months of speculation over potential buyers—Medtronic is reworking the ...
As a graduate student at the University of California, Los Angeles, Negin Majedi, Ph.D., developed an implantable, spongelike ...
Roche has participated in all of Freenome’s previous fundraising sessions and was also responsible for the $290 million ...
The National Institutes of Health is investing $515 million more into long COVID research efforts, three years after ...
Exscientia fired founder and CEO Andrew Hopkins after an internal investigation found that he had “inappropriate” ...
Tonix Pharmaceuticals has tapped CRO Rho to support the New Jersey-based biotech’s plans to submit a new drug application ...